Conservatives call for investigation of Spanish drugmakers’ use of Canadian

The Grifols headquarters in Barcelona in 2023. A Globe and Mail investigation found Canadian Blood Services is selling some blood components to the Spanish drugmaker to manufacture a product called albumin.

Conservative MPs are calling for a parliamentary investigation into Spanish drugmaker Grifols’s GIFOF use of Canadian-donated blood plasma to make medicines for sale abroad.

The call follows a Globe and Mail investigation that found Canadian Blood Services is selling some blood components to Grifols to manufacture a product called albumin, as part of a complex arrangement between the international pharmaceutical company and the Canadian charity to collect and process blood plasma.

Plasma is a straw-coloured fluid in blood used for transfusions and to make therapies such as immu